Singapore, Sep 23, 2009: Living Cell Technologies (LCT), a cell-based therapeutics developer with operations in Australia and New Zealand, has appointed Mr Bob Finder and Mr David McAuliffe as independent directors, and Dr David Brookes as chairman.

Mr Finder has over 35 years experience in the international biotech/pharmaceutical and chemical industries. He is chairman of the board of the ASX–listed LabTech System and a director on the board of National Pharmacies. He is a Member of the Australian Institute of Company Directors and of the American Institute of Chemical Engineers.

Mr McAuliffe has over 14 years experience in the international life science sector. During this time he has been involved in numerous capital raising and technology in-licensing exercises. He is the founder of NeuroDiscovery and has been a director since establishment. He founded several biotechnology companies in Australia, France and the UK, many of which have become public companies.

The newly appointed chairman, Dr Brookes has been an independent director since August 2009. “The company looks forward to an exciting new phase with the excellent early clinical data from our Diabecell trial and the addition of considerable industry experience from our new directors.”